15.09.2023 22:39:20
|
Johnson & Johnson Unveils Modernized Logo After 135 Years
(RTTNews) - In a significant departure from its iconic 135-year-old logo, Johnson & Johnson has unveiled a new corporate logo.
The traditional cursive signature, reminiscent of co-founder James Wood Johnson's handwriting, is being replaced with a contemporary font as the company shifts its focus towards medical devices and medications.
However, it's worth noting that while the corporate logo is changing, consumers may not immediately notice the difference. The cursive logo will continue to adorn familiar consumer products like Band-Aid and Tylenol.
This change comes in the wake of Johnson & Johnson's recent split into two separate entities: one focused on medical devices and medications and the other on consumer health products, operating under the brand name Kenvue.
The decision to introduce the Kenvue brand aligns with Johnson & Johnson's strategy to shift the corporate identity into the background and allow their well-established product brands to take center stage.
This approach is reminiscent of other consumer product conglomerates such as Unilever, the parent company of Dove and Hellmann's, and Procter & Gamble, which owns Bounty and Charmin. Kenvue began trading as an independent company a few weeks ago.
The retirement of the signature J&J logo marks the end of an era, as the company once proudly claimed it was one of the world's longest-used corporate emblems. Over time, the new logo will gradually replace the old one on Johnson & Johnson's medical equipment and pharmaceutical products.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
21.02.25 |
NYSE-Handel Dow Jones in der Verlustzone (finanzen.at) | |
21.02.25 |
Schwacher Handel in New York: Dow Jones mit Abgaben (finanzen.at) | |
20.02.25 |
Dow Jones aktuell: Dow Jones fällt letztendlich (finanzen.at) | |
20.02.25 |
Anleger in New York halten sich zurück: Dow Jones verliert (finanzen.at) | |
20.02.25 |
Dow Jones-Handel aktuell: Dow Jones notiert im Minus (finanzen.at) | |
19.02.25 |
Pluszeichen in New York: Dow Jones letztendlich mit positivem Vorzeichen (finanzen.at) | |
19.02.25 |
Handel in New York: Dow Jones gibt nach (finanzen.at) | |
19.02.25 |
NYSE-Handel Dow Jones am Mittwochmittag leichter (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 155,26 | 2,29% |
|